Shortages of pyrophosphate (PYP), the radiopharmaceutical most commonly used in the U.S. for noninvasive diagnosis of transthyretin (ATTR) cardiac amyloidosis, should not delay imaging in at-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback